Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1010

1.

MALT lymphoma with IgM paraprotein and bone marrow involvement mimicking Waldenström macroglobulinaemia.

Wang SC, Huang WT, Ma MC, Medeiros LJ, Chang KC.

Pathology. 2019 Jun 12. pii: S0031-3025(19)30038-8. doi: 10.1016/j.pathol.2019.03.005. [Epub ahead of print] No abstract available.

PMID:
31202483
2.

Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?

Chen Z, Sun Y, Xie W, Wang SA, Hu S, Li S, Tang Z, Toruner G, Medeiros LJ, Tang G.

Cancer Med. 2019 Jun 7. doi: 10.1002/cam4.2255. [Epub ahead of print]

3.

The emergence of a JAK2 V617F-mutated clone in myelodysplastic syndrome is associated with disease progression and features of myelofibrosis.

Zhong B, Medeiros LJ, Wang W.

Br J Haematol. 2019 May 28. doi: 10.1111/bjh.15984. [Epub ahead of print] No abstract available.

PMID:
31134612
4.

TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant.

Sakhdari A, Ok CY, Patel KP, Kanagal-Shamanna R, Yin CC, Zuo Z, Hu S, Routbort MJ, Luthra R, Medeiros LJ, Khoury JD, Loghavi S.

Ann Diagn Pathol. 2019 May 16;41:38-42. doi: 10.1016/j.anndiagpath.2019.05.004. [Epub ahead of print]

PMID:
31132650
5.

Genetic alterations and their clinical implications in DLBCL.

Miao Y, Medeiros LJ, Li Y, Li J, Young KH.

Nat Rev Clin Oncol. 2019 May 24. doi: 10.1038/s41571-019-0225-1. [Epub ahead of print] Review.

PMID:
31127191
6.

Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.

Khogeer H, Rahman H, Jain N, Angelova EA, Yang H, Quesada A, Ok CY, Sui D, Wei P, Al Fattani A, Pierce S, Loghavi S, Lamb A, Hu P, Thakral B, Kanagal-Shamanna R, Jorgensen JL, Jabbour EJ, Kantarjian HM, Medeiros LJ, Khoury JD.

Br J Haematol. 2019 May 22. doi: 10.1111/bjh.15960. [Epub ahead of print]

PMID:
31115909
7.

Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations.

Tang Z, Tang G, Hu S, Patel KP, Yin CC, Wang W, Lin P, Toruner GA, Ok CY, Gu J, Lu X, Khoury JD, Medeiros LJ.

Cancer Genet. 2019 Apr;233-234:21-31. doi: 10.1016/j.cancergen.2019.03.002. Epub 2019 Mar 11.

PMID:
31109591
8.

PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Aung PP, Sukswai N, Nejati R, Loghavi S, Chen W, Torres-Cabala CA, Yin CC, Konopleva M, Zheng X, Wang J, Tang Z, Medeiros LJ, Prieto VG, Pemmaraju N, Khoury JD.

Cancers (Basel). 2019 May 19;11(5). pii: E695. doi: 10.3390/cancers11050695.

9.

p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma.

Richardson AI, Yin CC, Cui W, Li N, Medeiros LJ, Li L, Zhang D.

Clin Lymphoma Myeloma Leuk. 2019 Apr 5. pii: S2152-2650(19)30169-7. doi: 10.1016/j.clml.2019.03.030. [Epub ahead of print]

PMID:
31078446
10.

The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.

Aladily TN, Mansour A, Alsughayer A, Sughayer M, Medeiros LJ.

Ann Diagn Pathol. 2019 Apr 23;40:72-76. doi: 10.1016/j.anndiagpath.2019.04.009. [Epub ahead of print]

PMID:
31075666
11.

CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form and a better prognosis.

Saksena A, Yin CC, Xu J, Li J, Zhou J, Wang SA, Lin P, Tang G, Wang L, Wang M, Miranda RN, Medeiros LJ, Li S.

Hum Pathol. 2019 May 2. pii: S0046-8177(19)30075-9. doi: 10.1016/j.humpath.2019.04.010. [Epub ahead of print]

PMID:
31054894
12.

CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.

Miao Y, Lin P, Saksena A, Xu J, Wang M, Romaguera J, Yin CC, Medeiros LJ, Li S.

Am J Surg Pathol. 2019 Apr 30. doi: 10.1097/PAS.0000000000001278. [Epub ahead of print]

PMID:
31045891
13.

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma.

Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, Samaniego F, Rodriguez MA, Rich AE, Medeiros LJ, Dabaja BS.

Blood Adv. 2019 May 14;3(9):1356-1367. doi: 10.1182/bloodadvances.2018029140.

14.

Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.

Xie W, Chen Z, Wang SA, Hu S, Li S, Miranda RN, Medeiros LJ, Tang G.

Leuk Lymphoma. 2019 Apr 24:1-9. doi: 10.1080/10428194.2019.1605509. [Epub ahead of print]

PMID:
31017498
15.

Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes.

Xie W, Wang SA, Yin CC, Xu J, Li S, Bueso-Ramos CE, Medeiros LJ, Tang G.

Exp Mol Pathol. 2019 Jun;108:131-136. doi: 10.1016/j.yexmp.2019.04.009. Epub 2019 Apr 17.

PMID:
31004601
16.

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.

Quesada AE, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Khoury JD, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, Bannon SA, Benton CB, Garcia-Manero G, Kantarjian H, Luthra R, Medeiros LJ, Patel KP.

Am J Hematol. 2019 Jul;94(7):757-766. doi: 10.1002/ajh.25486. Epub 2019 May 7.

PMID:
30963592
17.

Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy.

Sakhdari A, Tang G, Ginsberg LE, Hirsch-Ginsberg CF, Bueso-Ramos CE, Medeiros LJ, Miranda RN.

Case Rep Pathol. 2019 Mar 3;2019:4915086. doi: 10.1155/2019/4915086. eCollection 2019.

18.

Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phase.

Hidalgo-Lopez JE, Kanagal-Shamanna R, Reyes S, Zhao C, Medeiros LJ, Bueso-Ramos CE.

Ann Diagn Pathol. 2019 Mar 19;40:45-48. doi: 10.1016/j.anndiagpath.2019.03.001. [Epub ahead of print]

PMID:
30928887
19.

Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments.

Hu B, Patel KP, Chen HC, Wang X, Wang F, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating MJ, Wierda WG.

Br J Haematol. 2019 Jun;185(5):852-864. doi: 10.1111/bjh.15877. Epub 2019 Mar 28.

PMID:
30924136
20.

Relapsed B-acute lymphoblastic leukemia with aberrant myeloperoxidase expression following CAR T-cell therapy: A diagnostic challenge.

Li N, Wang SA, Lin P, Jabbour E, Thompson P, Chen Z, Li S, Xu J, You MJ, Bueso-Ramos CE, Medeiros LJ, Yin CC.

Am J Hematol. 2019 Mar 27. doi: 10.1002/ajh.25478. [Epub ahead of print] No abstract available.

PMID:
30916805
21.

Unusual case of human herpesvirus 8-positive large B-cell lymphoma associated with Castleman disease.

Sukswai N, Lyapichev K, Medeiros LJ, Khoury JD.

Clin Case Rep. 2019 Feb 7;7(3):587-588. doi: 10.1002/ccr3.2015. eCollection 2019 Mar.

22.

Liquid Biopsy Assay for Lung Carcinoma Using Centrifuged Supernatants from Fine Needle Aspiration Specimens.

Hannigan B, Ye W, Mehrotra M, Lam V, Bolivar A, Zalles S, Barkoh BA, Duose D, Hu PC, Broaddus R, Stewart J, Heymach J, Medeiros LJ, Wistuba I, Luthra R, Roy-Chowdhuri S.

Ann Oncol. 2019 Mar 18. pii: mdz102. doi: 10.1093/annonc/mdz102. [Epub ahead of print]

PMID:
30887015
23.

Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets.

Miao Y, Medeiros LJ, Xu-Monette ZY, Li J, Young KH.

Front Oncol. 2019 Mar 1;9:107. doi: 10.3389/fonc.2019.00107. eCollection 2019. Review.

24.

Biclonal presentation of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.

Wang W, Ding Y, Campbell A, Handy BC, Medeiros LJ, Lin P.

Pathology. 2019 Apr;51(3):340-343. doi: 10.1016/j.pathol.2018.10.022. Epub 2019 Mar 4. No abstract available.

PMID:
30846229
25.

Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Collins MS, Miranda RN, Medeiros LJ, Silva de Meneses MP, Iyer SP, Butler CE, Liu J, Clemens MW.

Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S-50S. doi: 10.1097/PRS.0000000000005568.

PMID:
30817555
26.

Pioneers of Breast Implant-Associated Anaplastic Large Cell Lymphoma: History from Case Report to Global Recognition.

Miranda RN, Medeiros LJ, Ferrufino-Schmidt MC, Keech JA Jr, Brody GS, de Jong D, Dogan A, Clemens MW.

Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):7S-14S. doi: 10.1097/PRS.0000000000005564.

PMID:
30817551
27.

American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.

O'Malley DP, Dogan A, Fedoriw Y, Medeiros LJ, Ok CY, Salama ME.

Ann Diagn Pathol. 2019 Apr;39:105-110. doi: 10.1016/j.anndiagpath.2019.02.001. Epub 2019 Feb 6.

PMID:
30802809
28.

Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.

Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee HJ, Westin J, Fowler N, Nastoupil L, Dabaja B.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):447-455. doi: 10.1016/j.ijrobp.2019.02.002. Epub 2019 Feb 12.

PMID:
30769175
29.

SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.

Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, Hu Z, Lin P, Tang G, Yin CC, Wang M, Medeiros LJ, Li S.

Am J Surg Pathol. 2019 May;43(5):710-716. doi: 10.1097/PAS.0000000000001233.

PMID:
30768440
30.

Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.

Xie W, Hu S, Xu J, Chen Z, Medeiros LJ, Tang G.

Ann Hematol. 2019 May;98(5):1149-1157. doi: 10.1007/s00277-019-03637-7. Epub 2019 Feb 13.

PMID:
30759270
31.

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.

Xu-Monette ZY, Xiao M, Au Q, Padmanabhan R, Xu B, Hoe N, Rodríguez-Perales S, Torres-Ruiz R, Manyam GC, Visco C, Miao Y, Tan X, Zhang H, Tzankov A, Wang J, Dybkær K, Tam W, You H, Bhagat G, Hsi ED, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, van Krieken JH, Winter JN, Westin JR, Pham LV, Medeiros LJ, Rassidakis GZ, Li Y, Freeman GJ, Young KH.

Cancer Immunol Res. 2019 Apr;7(4):644-657. doi: 10.1158/2326-6066.CIR-18-0439. Epub 2019 Feb 11.

PMID:
30745366
32.

Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.

Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE, Khoury JD, Medeiros LJ, Dabaja BS, Nastoupil LJ.

Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):244-250. doi: 10.1016/j.clml.2018.12.016. Epub 2019 Jan 3.

PMID:
30686775
33.

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.

Li L, Sun R, Miao Y, Tran T, Adams L, Roscoe N, Xu B, Manyam GC, Tan X, Zhang H, Xiao M, Tzankov A, Visco C, Dybkaer K, Bhagat G, Tam W, Hsi ED, van Krieken JH, You H, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, Zhang M, Winter JN, Medeiros LJ, Rassidakis GZ, Vaupel CA, Li Y, Dakappagari N, Xu-Monette ZY, Young KH.

Mod Pathol. 2019 Jun;32(6):741-754. doi: 10.1038/s41379-018-0193-5. Epub 2019 Jan 21.

PMID:
30666052
34.

Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.

Ye W, Hannigan B, Zalles S, Mehrotra M, Barkoh BA, Williams MD, Cabanillas ME, Edeiken-Monroe B, Hu P, Duose D, Wistuba II, Medeiros LJ, Stewart J, Luthra R, Roy-Chowdhuri S.

Cancer Cytopathol. 2019 Mar;127(3):146-160. doi: 10.1002/cncy.22098. Epub 2019 Jan 8.

PMID:
30620446
35.

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.

Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, Medeiros LJ, Wang MI, Cohen JB, Calzada O, Churnetski MC, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose JM, Bast MA, Fenske TS, Narayana Rao Gari S, Maddocks KJ, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns TF, Donovan AM, Wagner-Johnston N, Messmer M, Mehta A, Anderson JK, Reddy N, Kovach AE, Landsburg DJ, Glenn M, Inwards DJ, Karmali R, Kaplan JB, Caimi PF, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual JE, Lue JK, Diefenbach C, Fisher RI, Barta SK.

J Clin Oncol. 2019 Feb 20;37(6):471-480. doi: 10.1200/JCO.18.00690. Epub 2019 Jan 7.

PMID:
30615550
36.

Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection.

Patel KP, Ruiz-Cordero R, Chen W, Routbort MJ, Floyd K, Rodriguez S, Galbincea J, Barkoh BA, Hatfield D, Khogeer H, Kanagal-Shamanna R, Yin CC, Zuo Z, Loghavi S, Ok CY, DiNardo CD, Luthra R, Medeiros LJ.

J Mol Diagn. 2019 Jan;21(1):89-98. doi: 10.1016/j.jmoldx.2018.08.002.

PMID:
30577887
37.

t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.

Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang Z.

J Mol Diagn. 2019 Mar;21(2):343-351. doi: 10.1016/j.jmoldx.2018.10.005. Epub 2018 Dec 19.

PMID:
30576868
38.

Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms.

Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA.

Onco Targets Ther. 2018 Dec 10;11:8937-8942. doi: 10.2147/OTT.S159843. eCollection 2018.

39.

Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors.

Xie W, Wang SA, Hu S, Xu J, Medeiros LJ, Tang G.

Cancer Genet. 2018 Dec;228-229:41-46. doi: 10.1016/j.cancergen.2018.08.002. Epub 2018 Aug 27.

PMID:
30553471
40.

Villous lymphocytes in splenic large B-cell lymphoma with diffuse red pulp infiltration.

Wang RC, Medeiros LJ, Chang KC.

Int J Hematol. 2019 Feb;109(2):133-134. doi: 10.1007/s12185-018-02566-x. Epub 2018 Dec 5. No abstract available.

PMID:
30519992
41.

Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.

Kanagal-Shamanna R, Jain P, Patel KP, Routbort M, Bueso-Ramos C, Alhalouli T, Khoury JD, Luthra R, Ferrajoli A, Keating M, Jain N, Burger J, Estrov Z, Wierda W, Kantarjian HM, Medeiros LJ.

Cancer. 2019 Feb 15;125(4):559-574. doi: 10.1002/cncr.31831. Epub 2018 Dec 3.

PMID:
30508305
42.

Levels of CD8+ tumor infiltrating lymphocytes correlate with disease burden in bone marrow of therapy Naïve multiple myeloma patients.

Hidalgo-Lopez JE, Higa MG, Ferrian S, Lin P, Blando J, Medeiros LJ, Bueso-Ramos CE.

Ann Diagn Pathol. 2018 Nov 28. pii: S1092-9134(18)30370-8. doi: 10.1016/j.anndiagpath.2018.11.008. [Epub ahead of print] No abstract available.

PMID:
30509755
43.

Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis.

Hu Z, Ramos CEB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Xu J, Verstovsek S, Lin P.

Hum Pathol. 2019 Mar;85:290-298. doi: 10.1016/j.humpath.2018.10.026. Epub 2018 Nov 15.

PMID:
30447300
44.

Chronic Myeloid Leukemia: Beyond BCR-ABL1.

Zhou T, Medeiros LJ, Hu S.

Curr Hematol Malig Rep. 2018 Dec;13(6):435-445. doi: 10.1007/s11899-018-0474-6. Review.

PMID:
30370478
45.

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.

Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, Ahmed S, Alousi AM, Dabaja B, Pinnix CC.

Adv Radiat Oncol. 2018 Jul 12;3(4):639-646. doi: 10.1016/j.adro.2018.07.001. eCollection 2018 Oct-Dec.

46.

CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.

Angelova E, Audette C, Kovtun Y, Daver N, Wang SA, Pierce S, Konoplev SN, Khogeer H, Jorgensen JL, Konopleva M, Zweidler-McKay PA, Medeiros LJ, Kantarjian HM, Jabbour EJ, Khoury JD.

Haematologica. 2019 Apr;104(4):749-755. doi: 10.3324/haematol.2018.205252. Epub 2018 Oct 25.

47.

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.

Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, Ahmed S, Medeiros LJ, Khoury JD, Garg N, Amini B, Dabaja BS, Pinnix CC.

Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e51-e61. doi: 10.1016/j.clml.2018.09.002. Epub 2018 Sep 10.

PMID:
30360985
48.

Correction: Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.

Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC.

Oncotarget. 2018 Sep 28;9(76):34449. doi: 10.18632/oncotarget.26205. eCollection 2018 Sep 28.

49.

Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens.

Rassidakis GZ, Herold N, Myrberg IH, Tsesmetzis N, Rudd SG, Henter JI, Schaller T, Ng SB, Chng WJ, Yan B, Ng CH, Ravandi F, Andreeff M, Kantarjian HM, Medeiros LJ, Xagoraris I, Khoury JD.

Blood Cancer J. 2018 Oct 19;8(11):98. doi: 10.1038/s41408-018-0134-z.

50.

Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation.

Garces S, Yin CC, Patel KP, Khoury JD, Manning JT Jr, Li S, Xu J, Pina-Oviedo S, Johnson MR, González S, Molgó M, Ruiz-Cordero R, Medeiros LJ.

Mod Pathol. 2019 Jan;32(1):16-26. doi: 10.1038/s41379-018-0152-1. Epub 2018 Oct 15.

PMID:
30323237

Supplemental Content

Loading ...
Support Center